RxDoctor Payments Data

Markus Jackson, MD

Interventional Pain Medicine · Modesto, CANPI 1548656937

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (49.5%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 14.4%. Reporting peaked in 2022 at $6,737 and has fallen 86.5% since, to $909 in 2025.

$20,284in general payments, 2019–2025

Across 226 payments — averaging $89.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Saluda Medical Americas, Inc.$3K
  • Boston Scientific$3K
  • Painteq LLC$3K
  • Si-bone, Inc.$2K
  • Spinal Simplicity, LLC$1K
  • plus $6K from 15 others
$16in research payments, 2019–2025

Across 1 payment — averaging $16.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Saluda Medical Americas, Inc.$16

What the payments were for

  • Consulting fees$4022%
  • Travel & lodging$10,04850%
  • Food & beverage$9,83348%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,284 in reported general payments places this provider in the 85th percentile of 188 interventional pain medicine providers in California.

See all interventional pain medicine providers in California

Medicare billing

Part B allowed, 2024
$122,937
Medicare patients
268
Services billed
1,099

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine27$10,864
Gabapentin57$2,360
Tizanidine Hcl17$2,308
Desipramine Hcl25$2,276
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen40$1,108
Fentanyl12$811
Oxycodone Hcl92$598
Cephalexin89$516
Methocarbamol22$284
Baclofen14$231
Methylprednisolone24$97
Tramadol Hcl14$36

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Modesto

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →